Kelly A. Romano - 02 Dec 2022 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Role
Director
Signature
/s/ Glenna Mileson, Attorney-in-Fact for Kelly A. Romano
Issuer symbol
ATHA
Transactions as of
02 Dec 2022
Net transactions value
+$98,700
Form type
4
Filing time
06 Dec 2022, 19:31:29 UTC
Previous filing
02 Jun 2022
Next filing
31 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATHA Common Stock Purchase $98,700 +30,000 +361% $3.29 38,315 02 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.23 to $3.31, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range.